Pharma Giants Clash Over Obesity Drug Deal as AI Fuels Market Concentration

Key TakeawaysPfizer (PFE) has launched two lawsuits against Novo Nordisk (NVO) and Metsera, alleging anticompetitive practices and breach of contract in a high-stakes battle for the obesity drug developer.Amazon (AMZN)'s cloud unit secured a $38 billion, seven-year deal with OpenAI, providing Nvidia (NVDA) GPUs and further fueling the AI boom while highlighting extreme market concentration in the S&P 500 (SPX).Australian media giants Seven West Media (SWM) and Southern Cross Austereo (SCA) have agreed to a ...